Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

99 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The PERK-eIF2α phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells.
Kusio-Kobialka M, Podszywalow-Bartnicka P, Peidis P, Glodkowska-Mrowka E, Wolanin K, Leszak G, Seferynska I, Stoklosa T, Koromilas AE, Piwocka K. Kusio-Kobialka M, et al. Among authors: koromilas ae. Cell Cycle. 2012 Nov 1;11(21):4069-78. doi: 10.4161/cc.22387. Epub 2012 Oct 24. Cell Cycle. 2012. PMID: 23095523 Free PMC article.
PERK and PKR: old kinases learn new tricks.
Raven JF, Koromilas AE. Raven JF, et al. Among authors: koromilas ae. Cell Cycle. 2008 May 1;7(9):1146-50. doi: 10.4161/cc.7.9.5811. Epub 2008 Feb 21. Cell Cycle. 2008. PMID: 18418049 Review.
99 results